Co-founder and Chief Executive Officer
Senti Bio
Chief Operating Officer
bit.bio
Cell Therapy Innovations Bring Promise for Future Cures
Originally Aired: May 18, 2022
Time: 11:00 am PT, 2:00 pm ET, 20:00 CET
On this GEN Live, we’ll be joined by two cell therapy experts whose companies are trailblazing a path in an old field to create new cures. Tim Lu is the co-founder and CEO of Senti Bio, a company that is building a synthetic biology platform for “next-generation” cell therapies using gene circuits. Kathyrn Corzo is the COO at bit.bio, a UK-based company that has developed a cell programming technology that enables precise, rapid, and scalable generation of reprogrammed human iPSC-derived cells.
A live Q&A session followed the presentations, offering a chance to pose questions to our expert panelists.